Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-02-04
DOI
10.3389/fimmu.2015.00029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
- (2015) Marcelo R.P. Freitas et al. Oncotarget
- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Anti-neoplastic properties of hydralazine in prostate cancer
- (2015) Inês Graça et al. Oncotarget
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
- (2015) Huili Li et al. Oncotarget
- Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
- (2014) Xiaolu Wang et al. BMC CANCER
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome
- (2014) Carmen S. Tellez et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Acetylation Facilitates Rapid and Robust Memory CD8 T Cell Response through Differential Expression of Effector Molecules (Eomesodermin and Its Targets: Perforin and Granzyme B)
- (2014) Y. Araki et al. JOURNAL OF IMMUNOLOGY
- Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
- (2014) G. Lal et al. JOURNAL OF IMMUNOLOGY
- Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer
- (2014) Daniel Abate-Daga et al. PLoS One
- Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
- (2014) Ilaria Naldi et al. PLoS One
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anticancer effects of HDAC inhibitors require the immune system
- (2014) Alison C West et al. OncoImmunology
- The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
- (2014) Dominique N Lisiero et al. Journal for ImmunoTherapy of Cancer
- Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
- (2013) Angelique W. Whitehurst Annual Review of Pharmacology and Toxicology
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model
- (2013) M D Reed et al. BRITISH JOURNAL OF CANCER
- An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
- (2013) A. C. West et al. CANCER RESEARCH
- Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
- (2013) Madeleine SQ Kortenhorst et al. Epigenetics
- A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer
- (2013) Gesine Hoffmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
- (2013) David M. Woods et al. MELANOMA RESEARCH
- Tenovin-D3, a Novel Small-Molecule Inhibitor of Sirtuin SirT2, Increases p21 (CDKN1A) Expression in a p53-Independent Manner
- (2013) A. R. McCarthy et al. MOLECULAR CANCER THERAPEUTICS
- Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
- (2013) Lisa M. Kopp et al. MOLECULAR IMMUNOLOGY
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines
- (2013) BARBORA FIALOVA et al. ONCOLOGY REPORTS
- Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
- (2013) Li-Xin Wang et al. PLoS One
- Inhibition of Histone Deacetylase 3 Causes Replication Stress in Cutaneous T Cell Lymphoma
- (2013) Christina E. Wells et al. PLoS One
- The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
- (2013) Shuo Chen et al. PLoS One
- Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells
- (2013) Nahzli Dilek et al. PLoS One
- Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
- (2013) Pei-Ming Yang et al. Scientific Reports
- Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
- (2012) Amir A. Toor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines
- (2012) Rémy Bosviel et al. BRITISH JOURNAL OF NUTRITION
- Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
- (2012) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death
- (2012) Koji Yamanegi INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells
- (2012) JING WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
- (2012) Myrna Candelaria et al. PLoS One
- Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation
- (2012) H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer
- (2011) Andreas Herbst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells
- (2011) M. Lauricella et al. BIOCHIMIE
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation
- (2011) Angie Yeung et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML
- (2011) J. M. Scandura et al. BLOOD
- Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
- (2011) J Šímová et al. BRITISH JOURNAL OF CANCER
- Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy
- (2011) Min-Yu Chen et al. CANCER
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
- (2011) Zhi-Qiang Ning et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and Immunotherapeutic Targeting of the SSX Family of Cancer-Testis Antigens in Prostate Cancer
- (2011) H. A. Smith et al. CANCER RESEARCH
- Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
- (2011) M. Rao et al. CANCER RESEARCH
- Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
- (2011) Steven A. Belinsky et al. CANCER RESEARCH
- Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
- (2011) Ludovic Halby et al. CHEMBIOCHEM
- Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment
- (2011) Tony Peled et al. EXPERIMENTAL HEMATOLOGY
- Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
- (2011) I. J. Huijbers et al. JOURNAL OF IMMUNOLOGY
- Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
- (2011) C. Trumpfheller et al. JOURNAL OF INTERNAL MEDICINE
- The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells
- (2010) Sonja Mandl-Weber et al. BRITISH JOURNAL OF HAEMATOLOGY
- Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor
- (2010) David Moffat et al. JOURNAL OF MEDICINAL CHEMISTRY
- The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
- (2010) Maika Almstedt et al. LEUKEMIA RESEARCH
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of cancer/testis antigens in prostate cancer is associated with disease progression
- (2010) Takahito Suyama et al. PROSTATE
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
- (2009) Leonard C. Edelstein et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
- (2009) Madhavi Billam et al. BREAST CANCER RESEARCH AND TREATMENT
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer
- (2009) Shahana Majid et al. CANCER
- Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas
- (2009) Helen P. Cathro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
- (2009) Barbara Seliger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
- (2009) K. Iljin et al. CLINICAL CANCER RESEARCH
- Antigen processing and presentation: TAPping into ABC transporters
- (2009) Erik Procko et al. CURRENT OPINION IN IMMUNOLOGY
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
- (2009) Daniela Carlisi et al. EUROPEAN JOURNAL OF CANCER
- Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
- (2009) D. Ritchie et al. HAEMATOLOGICA
- Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
- (2009) P. Agarwal et al. JOURNAL OF IMMUNOLOGY
- Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
- (2009) Z. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer
- (2009) Guru Sonpavde et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Curcumin is a potent DNA hypomethylation agent
- (2008) Zhongfa Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- Enhanced Functionality of CD4+CD25highFoxP3+ Regulatory T Cells in the Peripheral Blood of Patients with Prostate Cancer
- (2008) J. Yokokawa et al. CLINICAL CANCER RESEARCH
- Retracted: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells
- (2008) Nobuyuki Kikuno et al. INTERNATIONAL JOURNAL OF CANCER
- The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma
- (2008) Atsushi Natsume et al. INTERNATIONAL JOURNAL OF CANCER
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- Specific Activity of Class II Histone Deacetylases in Human Breast Cancer Cells
- (2008) V. Duong et al. MOLECULAR CANCER RESEARCH
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- DNA methylation landscapes: provocative insights from epigenomics
- (2008) Miho M. Suzuki et al. NATURE REVIEWS GENETICS
- Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
- (2008) E Lara et al. ONCOGENE
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mammalian DNA Methyltransferases: A Structural Perspective
- (2008) Xiaodong Cheng et al. STRUCTURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started